Effectiveness of Antitussives, Anticholinergics and Honey Versus Usual Care in Adults With Uncomplicated Acute Bronchitis.
Unknown Phase 4 NCT03738917
Study Description
This study, which is aimed at comparing the effectiveness of 3 symptomatic therapies (dextromethorphan, ipratropium and honey) associated with usual care and the usual care in adults with acute bronchitis, is a multicentre, pragmatic, parallel group, open randomised trial. Patients aged 18 or over with uncomplicated acute bronchitis, with cough <3 weeks as the main symptom, scoring ≥ 4 in either daytime or nocturnal cough on a 7-point Likert scale, will be randomised to one of the 4 groups. Sample: 668 patients. The primary outcome will be the number of days with moderate-severe cough.
Study Details
- Registry ID:
- NCT03738917
- Conditions:
- Acute Bronchitis
- Phase:
- Phase 4
- Target Enrollment:
- 668 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (16 sites)
-
Pineda de Mar Health Center
Pineda De Mar, Catalonia, Spain -
Singuerlin Health Center
Santa Coloma De Gramenet, Catalonia, Spain -
CAP Jaume I
Tarragona, Catalonia, Spain -
Molí Nou Health Center
Sant Boi De Llobregat, Catalonia, Spain -
Molí Nou Health Center
Sant Boi De Llobregat, Barcelona, Spain -
Cornellà - La Gavarra Health Center
Cornellà De Llobregat, Catalonia, Spain -
Cornellà - La Gavarra Health Center
Cornellà De Llobregat, Barcelona, Spain -
Via Roma Health Centre
Barcelona, Catalonia, Spain -
La Marina Health Center
Barcelona, Catalonia, Spain -
CAP Passeig Maragall (EAP Camp de l'Arpa)
Barcelona, Catalonia, Spain -
Nova Lloreda Health Center
Badalona, Catalonia, Spain -
Martí i Julià Health Center
Badalona, Catalonia, Spain -
Singuerlin Health Center
Santa Coloma De Gramenet, Barcelona, Spain -
Ca n'OriacHealth Center
Sabadell, Catalonia, Spain -
Pineda de Mar Health Center
Pineda De Mar, Barcelona, Spain -
Balaguer Health Center
Balaguer, Catalonia, Spain
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.